Jurata Thin Film is a leading brand that specializes in innovative thin film technology. Their proprietary thin films are designed to stabilize the three-dimensional structure of biologic materials, eliminating the need for cold chain logistics in the pharmaceutical industry. These films have been extensively validated and can stabilize biologics for up to three years at room temperature, maintaining the therapeutic efficacy of their payload.

One of the remarkable features of Jurata's thin films is their lightweight, compact, and temperature stability, which simplifies the transport, distribution, and storage of vaccines and biologics. Unlike traditional fill/finish processes, Jurata's process takes place at room temperature, reducing energy consumption and cycle time. This makes their technology particularly suitable for low- and middle-income countries and low-resource regions.

Moreover, Jurata's thin film technology offers versatile routes of administration, including buccal and sublingual delivery, as well as intranasal and parenteral routes. These non-invasive delivery methods improve the potency of biologics without the need for needles. If you are interested in exploring their technology for your company's therapeutics or partnering with Jurata, they invite you to contact them via the provided link.

Join the path of revolutionizing pharmaceutical logistics with Jurata Thin Film